by WatchfulEye » Fri 20 Jun 2008, 21:51:09
That video is a bit of scaremongering.
The name 'superbug' is commonly used in the popular media, but it is rather misleading. MRSA isn't necessarily any more virulent, contagious or harmful than the classical susceptible Staph. MRSA just means a Staph aureus organism that is resistant to the use of the classic antibiotic 'methicillin' and its variants such as 'flucloxacillin'.
Staph aureus has been around probably for as long as humanity, and has been a common cause of all manner of diseases, most commonly skin boils, but also a variety of other illnesses. e.g. a severe case of influenza can predispose to catching pneumonia and S. aureus is the number 1 organism that infects influenza weakened lungs.
When Pencillin was first introduced for medical use in the 50s, all Staph aureus isolated from patients were killed by penicillin. However, within just 2 years of the introduction of pencillin, doctors started reporting cases of Staph aureus where the organism was resistant to the effects of penicillin. By the 70s, pencillin sensitive staph aureus was the exception; most S aureus was resistant. The antibiotic methicillin was developed from penicillin and was highly effective, even against the new penicillin resistant forms.
Now we are starting to see MRSA appearing in increasing numbers. It's misleading to say that it's not treatable, but treating it is more difficult. Flucloxacillin is an excellent antibiotic with few side-effects, can be taken in tablet form, and penetrates deep into the tissues of the body - e.g. damaged or inflamed tissue. There are plenty of antibiotics that are effective against MRSA; doxycycline, trimethoprim, rifampicin, vancomycin, teicoplanin, linezolid are some just off the top of my head. There are several other unusual ones. However, these all tend to have some disadvantages - either they're of limited potency, and need to be taken in a cocktail of 2 or 3 different antibiotics, or they have potentially dangerous side effects which require careful medical supervision.
There are numerous different strains of S aureus, with different levels of virulence (how much disease they call). Some are relatively mild, and healthy people will just fight off the infection with barely any symptoms - may a bit of a spot on the skin. More virulent ones can cause boils/abscesses. And some of the most virulent ones can cause septicaemia, and horrendous infections causing serious illness and organ damage, even in healthy people with strong immune systems.
There's a particularly nasty type of virulence in S aureus called PVL (Panton-Valentine leukocidin). PVL positive S aureus can cause devastating 'necrotizing' (flesh eating) illness even in healthy people. There have been outbreaks of PVL+ MRSA in a number of countries; in Europe, Asia and the USA. However, PVL is not new - it was recognised in the 30s - just that it tends to attract attention because it's nasty.
There are a lot of factors that determine the prevlence and the development of MRSA. Overuse of antibiotics is certianly one - but it's not just overuse of methicilllin/flucloxacillin that is necessarily to blame. One thing relatively recently recognised is that other antibiotics may predispose. E.g. ciprofloxacin. Ciprofloxacin isn't particularly useful for Staph infections, but it is excellent for things like urine infections and gut infections (which are caused by different bugs e.g. E. coli). However, it's now recognised that receiving ciprofloxacin is a major risk factor for contracting MRSA; it completely cleans out all the 'friendly' bacteria that normally inhabit the skin, and is partially effective against staph aureus. However, the same genes that cause SA to become MRSA tend to confer resistance to cipro. So, if you take cipro, you preferrentially select the MRSA. This is such a problem where I've worked, that the hospital has now essentially banned the use of cipro, except on the orders of an attending microbiologist.
It's also perhaps disingenous to dismiss the recent initiatives such as rigorous attention to detail in hand washing, etc. In some countries, e.g. the UK, MRSA infections are reportable, and a lab reporting a positive significant culture (e.g. septicaemia) must report the result to the health protection agency. In recent years, there has been a significant decline in number of significant MRSA infections recorded in this way. The peak was in 2004, and the rate has decreased year-on-year in each subsequent year. Of course, the data to identifiy which intervention this can be attributed to doesn't exist - but it's likely that it's the combination of measures.